These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2782755)

  • 1. Prognosis of chronic obstructive pulmonary disease: the Dutch experience.
    Postma DS; Sluiter HJ
    Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S100-5. PubMed ID: 2782755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe chronic airflow obstruction: can corticosteroids slow down progression?
    Postma DS; Steenhuis EJ; van der Weele LT; Sluiter HJ
    Eur J Respir Dis; 1985 Jul; 67(1):56-64. PubMed ID: 4054257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility.
    Postma DS; Gimeno F; van der Weele LT; Sluiter HJ
    Eur J Respir Dis; 1985 Nov; 67(5):360-8. PubMed ID: 3878797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.
    Hansen EF; Phanareth K; Laursen LC; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1267-71. PubMed ID: 10194175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction.
    Postma DS; de Vries K; Koëter GH; Sluiter HJ
    Am Rev Respir Dis; 1986 Aug; 134(2):276-80. PubMed ID: 2874759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperresponsiveness as a determinant of the outcome in chronic obstructive pulmonary disease.
    Postma DS; Wempe JB; Renkema TE; van der Mark TW; Koëter GH
    Am Rev Respir Dis; 1991 Jun; 143(6):1458-62. PubMed ID: 2048838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
    Postma DS; Peters I; Steenhuis EJ; Sluiter HJ
    Eur Respir J; 1988 Jan; 1(1):22-6. PubMed ID: 3366234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
    Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ
    N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of airway obstruction in relation to prognosis in chronic obstructive pulmonary disease.
    Kawakami Y; Kishi F; Dohsaka K; Nishiura Y; Suzuki A
    Chest; 1988 Jan; 93(1):49-53. PubMed ID: 3335167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in severe chronic obstructive pulmonary disease.
    Postma DS; Burema J; Gimeno F; May JF; Smit JM; Steenhuis EJ; Weele LT; Sluiter HJ
    Am Rev Respir Dis; 1979 Mar; 119(3):357-67. PubMed ID: 443616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.
    Kerstjens HA; Overbeek SE; Schouten JP; Brand PL; Postma DS
    Eur Respir J; 1993 Jun; 6(6):868-76. PubMed ID: 8339808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.
    Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
    Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population.
    Burrows B; Bloom JW; Traver GA; Cline MG
    N Engl J Med; 1987 Nov; 317(21):1309-14. PubMed ID: 3683459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1.
    Rijcken B; Schouten JP; Xu X; Rosner B; Weiss ST
    Am J Respir Crit Care Med; 1995 May; 151(5):1377-82. PubMed ID: 7735588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease.
    Kerstjens HA; Brand PL; Postma DS
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 2):S266-72. PubMed ID: 8970399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago "COPD" series.
    Burrows B
    Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S92-4. PubMed ID: 2782767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Course and prognosis of chronic obstructive lung disease over 5 and 10 years].
    Brändli O; Langloh P; Plangger M; Dreher D
    Schweiz Med Wochenschr; 1988 Sep; 118(37):1314-20. PubMed ID: 3175577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible airflow obstruction. Evolution in asthma.
    Finucane KE; Greville HW; Brown PJ
    Med J Aust; 1985 May; 142(11):602-4. PubMed ID: 4000023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term course following respiratory decompensation in chronic obstructive pulmonary disease (COPD)].
    Russi EW
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1729-32. PubMed ID: 1957146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.